Mingzhi Han et al. demonstrate that SFPR2 is downregulated in glioma patients and predicts poor overall survival and progression-free survival, while overexpression of SFRP2 suppresses sphere formation, invasion and tumor growth of glioblastoma cells by regulating Wnt/β-catenin signaling [21]. This evidence concerns the gene SFRP2 and neoplasm.